Showing results (151-160 of 197) with videos related to

Sort By:
Pageof 20
International Journal of Oncology|February 10, 2004
Prediction of response to neoadjuvant chemotherapy for osteosarcoma by gene-expression profilesKensuke Ochi, Yataro Daigo, Toyomasa Katagiri, et al.
Cancer Science|June 29, 2018
α-particle therapy for synovial sarcoma in the mouse using an astatine-211-labeled antibody against frizzled homolog 10Huizi Keiko Li, Aya Sugyo, Atsushi B Tsuji, et al.
Annals of Surgical Oncology|August 22, 2013
Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imagingTakashi Akiyoshi, Masashi Ueno, Kiyoshi Matsueda, et al.
Cancer Medicine|March 23, 2022
Development and evaluation of a colorectal cancer screening method using machine learning-based gut microbiota analysisYusuke Konishi, Shintaro Okumura, Tomonori Matsumoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 4, 2018
[Safety of Laparoscopic Surgery after Preoperative Short Course Radiotherapy for Lower Rectal Cancer]Hironori Minami, Tsuyoshi Konishi, Hironori Fukuoka, et al.
Diseases of the Colon and Rectum|July 9, 2020
Adding Narrow-Band Imaging to Chromoendoscopy for the Evaluation of Tumor Response to Neoadjuvant Therapy in Rectal CancerMitsuaki Ishioka, Akiko Chino, Daisuke Ide, et al.
Oncology|December 15, 2010
Oxaliplatin-free interval as a risk factor for hypersensitivity reaction among colorectal cancer patients treated with FOLFOXYukiko Mori, Takafumi Nishimura, Toshiyuki Kitano, et al.
Chemotherapy|September 11, 2008
Safety and efficacy of modified FOLFOX6 for treatment of metastatic or locally advanced colorectal cancer. A single-institution outcome studyShigemi Matsumoto, Takafumi Nishimura, Masashi Kanai, et al.
Molecular Cancer Therapeutics|February 10, 2017
<i>APC</i> Mutations as a Potential Biomarker for Sensitivity to Tankyrase Inhibitors in Colorectal CancerNoritaka Tanaka, Tetsuo Mashima, Anna Mizutani, et al.
Cell Reports|December 17, 2024
Longitudinal phosphoproteomics reveals the PI3K-PAK1 axis as a potential target for recurrent colorectal liver metastasesDaigo Gunji, Yuichi Abe, Satoshi Muraoka, et al.
Pageof 20